We are live on ! Find out more
GMO

General Moly, Inc.
GMO

Delisted

GMO was delisted on the 30th of September, 2020.

48 hedge funds and large institutions have $5.61M invested in General Moly, Inc. in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

2% less funds holding

Funds holding: 4948 (-1)

27% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 11

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

55% less capital invested

Capital invested by funds: $12.4M → $5.61M (-$6.82M)

Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
12
Increased
8
Reduced
11
Closed
11
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
+$9K
Name Holding Trade Value Shares
Change
Change in
Stake
GC
26
Guggenheim Capital
Illinois
$8K +$8.2K +14,555 New
BIM
27
BlackRock Investment Management
Delaware
$6K
Stifel Financial
28
Stifel Financial
Missouri
$6K
UBS Group
29
UBS Group
Switzerland
$6K +$5.63K +10,000 New
Renaissance Technologies
30
Renaissance Technologies
New York
$6K +$6.42K +11,400 New
TRCT
31
Tower Research Capital (TRC)
New York
$4K -$2.77K -4,914 -39%
Wells Fargo
32
Wells Fargo
California
$3K -$3.66K -6,500 -57%
Morgan Stanley
33
Morgan Stanley
New York
$2K -$13.1K -23,200 -92%
BC
34
Bartlett & Co
Ohio
$2K +$479 +850 +40%
Creative Planning
35
Creative Planning
Kansas
$2K +$2.25K +4,000 New
Bank of Montreal
36
Bank of Montreal
Ontario, Canada
$1K
ST
37
Smithfield Trust
Pennsylvania
$1K
RMAM
38
Raab & Moskowitz Asset Management
New Jersey
$1K +$563 +1,000 New
Citigroup
39
Citigroup
New York
$1K +$890 +1,580 +308%
NPC
40
National Planning Corporation
California
$289 +$282 +500 New
AIG
41
American International Group
New York
$57
MPWT
42
MassMutual Private Wealth & Trust
Connecticut
$50
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2
VanEck Associates
44
VanEck Associates
New York
-$1.2M -1,605,999 Closed
CCA
45
Catalyst Capital Advisors
New York
-$78K -105,000 Closed
Nomura Holdings
46
Nomura Holdings
Japan
-$63K -80,000 Closed
AI
47
ArchPoint Investors
Florida
-$31K -41,769 Closed
LP
48
LMR Partners
United Kingdom
-$25K -34,605 Closed
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
-$22K -29,900 Closed
T. Rowe Price Associates
50
T. Rowe Price Associates
Maryland
-$17K -22,800 Closed

GMO Hedge Fund Activity: Q4 2014 in Review

48 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in General Moly, Inc. (GMO) for Q4 2014, worth a combined $5.61M — down 55% from $12.4M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new GMO positions and 11 closed out — a net gain of 1 holder — while 8 added to existing stakes and 11 trimmed.

The largest buyer was Millennium Management, adding an estimated $80.6K. The largest seller was VanEck Associates, exiting entirely with an estimated $1.2M sold.

  • 48 institutional investors held General Moly, Inc. (GMO) as of Q4 2014, down from 49 in Q3 2014.
  • Funds reported $5.61M of General Moly, Inc. stock for Q4 2014, down 55% quarter-over-quarter.
  • 12 funds opened new General Moly, Inc. positions in Q4 2014 and 11 closed out, a net change of +1 holder.
  • The largest General Moly, Inc. buyer in Q4 2014 was Millennium Management, an estimated $80.6K added.
  • The largest General Moly, Inc. seller in Q4 2014 was VanEck Associates, an estimated $1.2M sold.

Based on aggregated 13F filings for Q4 2014.